MDG — Medicalgorithmics SA Income Statement
0.000.00%
- PLN245.83m
- PLN251.55m
- PLN24.00m
Annual income statement for Medicalgorithmics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 112 | 48.3 | 62.7 | 43.1 | 24 |
Cost of Revenue | |||||
Gross Profit | 103 | 38.4 | 50.4 | 35.9 | 20.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 149 | 58 | 45.5 | 42.7 | 40.5 |
Operating Profit | -37.5 | -9.63 | 17.2 | 0.433 | -16.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -40 | -7.01 | 25.3 | -0.238 | -15.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -27.7 | -6.57 | 25.5 | -0.578 | -16.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12.9 | -181 | -11.9 | -0.578 | -16.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.9 | -181 | -11.9 | -0.578 | -16.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.27 | 1.67 | 4.33 | -0.05 | -1.44 |
Dividends per Share |